Vascular endothelial growth factor (VEGF) promotes immune suppression by enhancing the influx of suppressive cell types into the tumor microenvironment (TME), modulating the activity of myeloid-derived suppressor cells (MDSCs) and Treg cells, inhibiting the maturation of dendritic cells (DCs) [18, 19]. This evidence concerns the gene VEGFA and neoplasm.